11 May 2021
						
				SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic
SpeeDx announced it has been awarded up to US $1.8 million from CARB-X to address the rising threat of drug-resistant bacteria. Funds will be used to develop a rapid test for the combined...
 
 			  
				